🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Indian shares post record closing highs in catch-up trade

Published 17-11-2020, 04:07 pm
SSABa
-
PFE
-
NSEI
-
NSEBANK
-
NIFTYMET
-
HDBK
-
TISC
-
BSESN
-
MRNA
-

BENGALURU, Nov 17 (Reuters) - Indian shares notched record closing highs on Tuesday, playing catch-up with overseas gains after a long holiday weekend and bolstered by news that U.S. drugmaker Moderna Inc's coronavirus vaccine was 94.5% effective in preventing infection.

The blue-chip NSE Nifty 50 index .NSEI ended up 0.74% at 12,874.20, while the benchmark S&P BSE Sensex .BSESN closed 0.72% higher at 43,952.71.

Markets had eked out modest gains in a one-hour special "muhurat" trading session for Diwali on Saturday, and were closed on Monday.

Moderna Inc MRNA.O became the second drugmaker after Pfizer Inc (NYSE:PFE) PFE.N to announce promising trial data in the development of a COVID-19 vaccine, pushing global markets higher. MKTS/GLOB

Moderna's vaccine is expected to be stable at normal fridge temperatures of 2 to 8 degrees Celsius (36 to 48°F) for 30 days, making it easier for storage and transportation than Pfizer's vaccine.

Indian equities have gained more than 10% so far in November, helped by signs of a demand recovery, a strong earnings season, and higher fund inflows.

Daily coronavirus infections in the country have also been falling since hitting a peak in September, and cases in the last 24 hours rose by their lowest since mid-July. Mumbai, the Nifty Bank Index .NSEBANK closed 2.05% higher and the Nifty Metal Index .NIFTYMET ended up 2.49%.

HDFC Bank Ltd HDBK.NS was the top boost to the Nifty, rising 2.8%.

Tata Steel Ltd TISC.NS closed 6.2% higher after the company late on Friday said it was in talks with Swedish steelmaker SSAB SSABa.ST to sell its Dutch steel mill and related assets.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.